FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - Immunization, Realm US

19,481 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 18400 - 18600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
hl7.fhir.us.davinci-pasR4ValueSet/PASCommunicationRequestMediumPAS Communication Medium Value Settrial-use3fm2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3210Contact Type (Hepatitis B)active2009-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.69.5Advance Directives Content Typesactive2024-04hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-cytologic-evidence-malignancy-vsCytologic Evidence of Malignancy Value Setactive4cic2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3211Material exposure typeactive2009-01
hl7.fhir.us.mcodeR4ValueSet/mcode-hypereosinophilic-syndrome-disorder-vsSpecific Diagnosis of Cancer Value Setactive4cic2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7732Infection Type (RIBD)active2018-01
hl7.fhir.us.davinci-drug-formularyR4ValueSet/InsuranceItemTypeVSInsurance item typetrial-usephx2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3133Live Birth Outcome (Rubella)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1006Type of Long Term Care Facilityactive2019-01
hl7.fhir.us.mcodeR4ValueSet/mcode-melanoma-in-situ-disorder-vsMelanoma In-Situ Disorder Value Setactive4cic2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3135Non-Live Birth Outcome (VPD)active2008-01
hl7.fhir.us.mcodeR4ValueSet/mcode-primary-malignant-neoplasm-disorder-vsPrimary Malignant Neoplasm Disorder Value Setactive4cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-primary-cancer-disorder-vsPrimary Cancer Disorder Value Setactive4cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-cancer-staging-prognostic-factor-type-vsCancer Staging Prognostic Factors Typesactivecic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-secondary-cancer-disorder-vsSecondary Cancer Disorder Value Setactive4cic2025-02hl7
hl7.fhir.us.davinci-pasR4ValueSet/PASSupportingInfoTypePAS Supporting Info Type Value Settrial-use3fm2025-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.22.5.300Transmission Based Precaution Typesactive2024-06hl7
hl7.cda.us.eyecareR5ValueSet/AidToVisionCodesAid to Vision Codesdraft2024-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7941Job Setting (COVID-19)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7647Typhoid Paratyphoid Serotype (FDD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3111Typhoid Signs Symptoms (FDD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3590Pulse Oximetry Unitactive2010-01
fhir.virtually.healthcareR4ValueSet/UKCorrelationIdentifierUK Common Resource Identifiersdraft2025-08hl7
fhir.virtually.healthcareR4ValueSet/UKNationalIdentifiersUK National Insurance Identifiersdraft2025-08hl7
fhir.virtually.healthcareR4ValueSet/ProfessionalLicenseUK Professional Licensedraft2025-08hl7
fhir.virtually.healthcareR4ValueSet/StaffNumberUK StaffNumberdraft2025-08hl7
hl7.fhir.us.davinci-pctR4ValueSet/USClaimDRGCodesUS Claim DRG Codestrial-usefm2025-08hl7
fhir.cdc.opioid-cds-r4R4ValueSet/condition-us-core-health-concern-categoryUS Core Health Concern Condition Categoryactive2023-05hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.973Cityactive2020-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.4469Cabotegravir Injectable Productsactive2024-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.4470Emtricitabine oral for HIV PrEPactive2024-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.4474HIV Laboratory Based Testsactive2024-05hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3322Underlying Conditions (IPD)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7681Underlying Condition (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7947Risk Factor (COVID-19)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3112Underlying Conditionsactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3402Age Unit (Syndromic Surveillance)active2011-01
hl7.fhir.us.codex-radiation-therapyR4ValueSet/codexrt-image-guided-radiotherapy-energy-unit-vsImage Guided Radiotherapy Energy Unit Value Setdraftcgp2025-02hl7
hl7.fhir.us.codex-radiation-therapyR4ValueSet/codexrt-radiotherapy-energy-unit-vsRadiotherapy Energy Unit Value Setdraftcgp2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7667Eosinophil Unitsactive2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.891Height Unitactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7372Time Units (NCHS)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.879Weight Unitactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7906Test result units (ARLN)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.838Units of Measureactive2015-01
hl7.fhir.us.pq-cmc-fdaR5ValueSet/pqcmc-non-percentage-unitsNon-Percentage Unitstrial-use2brr2025-07hl7
hl7.fhir.us.pq-cmc-fdaR5ValueSet/pqcmc-percentage-unitsPercentage Unitstrial-use2brr2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.920Blood Pressure Unitactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.878Age unitactive2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.919Temperature Unitactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7819Unit of Measure (TB)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7451Type of Testing at CDC (VZ)active2015-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7452Age Unit (NND)active2015-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7453Body Region(s) of Rashactive2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7454Character of Lesionsactive2015-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7474Type of Complication (VZ)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7456Lab Test Type (Varicella)active2018-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.41Tobacco Useactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.90Gestational Diabetesactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.526.2.1921Beta Blocker Therapy Ingredientactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.526.3.1493Beta Blocker Therapy Ingredientactive2017-05hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.822Referral Priority (HL7)active2008-01
fhir.cdc.opioid-cds-r4R4ValueSet/cocaine-urine-drug-screening-testsCocaine urine drug screening testsactive2023-05hl7
fhir.cdc.opioid-cds-r4R4ValueSet/fentanyl-type-urine-drug-screening-testsFentanyl-type urine drug screening testsactive2023-05hl7
fhir.cdc.opioid-cds-r4R4ValueSet/opiate-specific-urine-drug-screening-testsOpiate specific urine drug screening testsactive2023-05hl7
fhir.cdc.opioid-cds-r4R4ValueSet/phencyclidine-urine-drug-screening-testsPhencyclidine urine drug screening testsactive2023-05hl7
fhir.cdc.opioid-cds-r4R4ValueSet/synthetic-opioid-urine-drug-screening-testsSynthetic opioid urine drug screening testsactive2023-05hl7
fhir.cdc.opioid-cds-r4R4ValueSet/all-urine-drug-screening-testsAll urine drug screening testsactive2023-11hl7
fhir.cdc.opioid-cds-r4R4ValueSet/methadone-urine-drug-screening-testsMethadone urine drug screening testsactive2023-05hl7
fhir.cdc.opioid-cds-r4R4ValueSet/amphetamine-urine-drug-screening-testsAmphetamine-class drugs and metabolite urine testsactive2023-05hl7
hl7.fhir.us.vdorR4ValueSet/vdor-use-of-prescription-morphine-vsVDOR Use of Prescription Morphineinformativepher2025-06hl7
signal.core.r4R4ValueSet/contact-point-useContactPointUsedraft0fhir2019-10hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.2.11.7101VPD Reason for Studyactive2013-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.227Neoplasm of Brainactive2024-07hl7
hl7.fhir.us.carin-bbR4ValueSet/C4BBAdjudicationCategoryDiscriminatorC4BB Adjudication Category Discriminator Value Settrial-usefm2025-02hl7
hl7.fhir.us.davinci-pdexR4ValueSet/PDexAdjudicationCategoryDiscriminatorPDex Adjudication Category Discriminatorinformativefm2025-06hl7
hl7.fhir.us.carin-bbR4ValueSet/C4BBSupportingInfoTypeC4BB SupportingInfo Type Value Settrial-usefm2025-02hl7
hl7.fhir.us.davinci-pdexR4ValueSet/PDexSupportingInfoTypePDex SupportingInfo Typeinformativefm2025-06hl7
hl7.fhir.us.carin-bbR4ValueSet/C4BBTotalCategoryDiscriminatorC4BB Total Category Discriminator Value Settrial-usefm2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7367Exposure Time Frame (NND)active2015-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.44Mental and Functional Status Responseactive2024-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.5015Role (PHLIP)active2011-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.244Anthracycline Injectableactive2024-10hl7
hl7.fhir.us.coreR4ValueSet/us-core-clinical-result-observation-categoryUS Core Clinical Result Observation Categorytrial-use3cgp2023-04hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7378Death Reporting Name Type Code (NCHS)active2016-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.11610x_ActRelationshipDocumentactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.16926HL7 BasicConfidentialityKindactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1029.67Other Health Care Facilityactive2025-05hl7
us.cdc.phinvadsR4ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.2JCIH-EHDI Outpatient Encounteractive2010-01
hl7.fhir.us.pacio-pfeR4ValueSet/pfe-survey-category-vsPersonal Functioning and Engagement Survey Value Settrial-use3pc2025-07hl7
hl7.fhir.us.icsr-ae-reportingR4ValueSet/ICSRAESeriousnessICSR Top-Level Seriousnessdraft2023-08hl7
signal.core.r4R4ValueSet/data-absent-reasonDataAbsentReasonnormative5fhir2019-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1240.4Asked Declined Data Absent Reasonactive2023-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7442Death Reporting Event Type (NCHS)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3363Patient Class (IIS)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3365Relationship (IIS)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3366Financial Class (IIS)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3372Identifier Type (IIS)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3373Organizational Name Type (IIS)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3374Query Response Status (IIS)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3384Publicity Code (IIS)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3377Immunization Registry Status (HL7)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3378Immunization Registry Status (IIS)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3379Query Name (IIS)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.814Religion (HL7)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.816Route of Administration (HL7)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.812Production Class (HL7)active2008-01
signal.core.r4R4ValueSet/questionnaire-dacods-admission-route-of-administrationQuestionnaire DACODS Admission Route Of Administrationdraft1pahl7
signal.core.r4R4ValueSet/questionnaire-dacods-discharge-route-of-administrationQuestionnaire DACODS Discharge Route Of Administrationdraft1pahl7
fhir.virtually.healthcareR4ValueSet/VHConditionCodeVH Condition Codedraft2025-08hl7
fhir.virtually.healthcareR4ValueSet/VHImmunisationCodeVH Immunisation Codedraft2025-08hl7
fhir.virtually.healthcareR4ValueSet/VHMedicationCodeVH Medication Codedraft2025-08hl7
fhir.virtually.healthcareR4ValueSet/VHObservationCodeVH Observation Codedraft2025-08hl7
fhir.virtually.healthcareR4ValueSet/VHObservationValueCodeVH Observation Value Codedraft2025-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.9ER Test for Orserduactive2023-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1248.185Spinal Surgeryactive2024-06hl7
fhir.giisR4ValueSet/VaccinationSiteVSVaccination body sitedraft2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7689Vaccination Information Source (RIBD)active2018-01
fhir.giisR4ValueSet/VaccinationReasonVSVaccination reasondraft2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.934Vaccines administered (CVX)active2022-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3410Vaccine Not Given Reasons (NETSS)active2011-01
fhir.giisR4ValueSet/VaccineVSVaccine codesdraft2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7646Vaccine Received (FDD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1049Substance Administered (CRA)active2008-01
hl7.fhir.us.registry-protocolsR4ValueSet/NCDRErrorsVSNCDRErrorsVSactivecic2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.526.3.1489ACE Inhibitor or ARB or ARNI Ingredientactive2023-02hl7
hl7.fhir.us.davinci-pctR4ValueSet/PCTAdjudicationCategoryVSPCT GFE Item Adjudication Value Settrial-usefm2025-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.22.5.305Microbiology and Antimicrobial Susceptibility Testsactive2024-06hl7
hl7.fhir.us.directory-queryR4ValueSet/OrganizationAffiliationRoleVSOrganizationAffiliation Rolesactive2022-12hl7
hl7.fhir.us.davinci-pdex-plan-netR4ValueSet/OrganizationAffiliationRoleVSOrganizationAffiliation Rolestrial-usefm2025-02hl7
hl7.fhir.us.ndhR4ValueSet/OrganizationAffiliationRoleVSOrganizationAffiliation Rolestrial-usepa2025-07hl7
hl7.fhir.us.directory-attestationR4ValueSet/OrganizationAffiliationRoleVSOrganizationAffiliation Rolesactive2022-12hl7
hl7.fhir.us.qicoreR4ValueSet/qicore-present-on-admissionQICore Present On Admission Codestrial-use4cqi2021-05hl7
fhir.nigeriaImmunizationR4ValueSet/register-client-valuesetIMMZ.C Value Set for Registering Clientsactive2025-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.37TargetSite Qualifiersactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1099.29Allergy Clinical Statusactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.1Administrative Gender (HL7 V3)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.20.2Advance Directive Type Codeactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.3221.8.9Body Site Value Setactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.18877Coverage Role Type Value Setactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.26EntityPersonNamePartQualifieractive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.12212Marital Statusactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.33INDRoleclassCodesactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.80.64Medication Fill Statusactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.18MoodCodeEvnIntactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.25Planned moodCode (Observation)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.24Planned moodCode (SubstanceAdministration/Supply)active2024-06hl7
fhir.kenyaPSIGR4ValueSet/medication-vsMedication Value Setdraft2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3392Value Type (IIS)active2018-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.101Myocardial Infarctionactive2024-02hl7
hl7.fhir.us.breastcancerR3ValueSet/oncology-HER2FISHMethodVSBC HER2FISHMethodVS ValueSetdraft2018-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8001Time of Day (CDC)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7265Duration Unitactive2020-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.110Corticosteroid Ingredients and Risk of GI Bleedingactive2023-12hl7
hl7.fhir.us.breastcancerR3ValueSet/oncology-HER2byIHCScoreVSBC HER2byIHCScoreVS ValueSetdraft2018-08hl7
hl7.fhir.us.breastcancerR3ValueSet/shr-core-PositiveNegativeVSBC PositiveNegativeVS ValueSetdraft2018-08hl7
hl7.fhir.us.breastcancerR3ValueSet/shr-core-PositiveNegativeIndeterminateVSBC PositiveNegativeIndeterminateVS ValueSetdraft2018-08hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-lansky-play-performance-vsLansky Play Performance Status VSactivecic2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.249pralsetinibactive2024-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7777Healthcare Service Location (Syndromic)active2020-01
hl7.fhir.us.physical-activityR4ValueSet/pa-goal-target-measurePA Goal Target Measure Codesinformativepc2024-03hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.954BioSense Observationsactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7333Timing of Maternal Treatment (NND)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3045Microorganism (Hepatitis)active2016-01
hl7.fhir.us.odhR4ValueSet/obf-datatype-YesNoVSYes No VSdraft2020-01hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6062Observation Result Status Interpretation Codesactive2012-01
hl7.fhir.us.pq-cmc-fdaR5ValueSet/cmc-comp-section-types-vseCTD sections Terminologytrial-use2brr2025-07hl7
hl7.fhir.us.pcoR4ValueSet/pco-goal-domain-categoriesPCO Goal Domain Categoriesdraft2pc2025-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7911Clinical sample or isolate (ARLN)active2019-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.22Pregnancy Intentionactive2023-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7228CSF WBC Protein Result (NND)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7950Yes No Unknown NA (NND)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7486Yes No Not Applicable (NCHS)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.888Yes No Unknown (YNU)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7193YNRD (CDC)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.819Yes No Indicator (HL7)active2018-12
fhir.r4.nhsengland.programmeR4ValueSet/England-Endpoint-BusinessScenarioEngland Endpoint Business Scenariodraft2025-07hl7
fhir.nigeriaImmunizationR4ValueSet/IMMZD16-ValueSetIMMZ.E.DE.5 ValueSet for AEFI Treatmentactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/vaccine-diluent-vsIMMZI - ValueSet for Vacine Stock Levelsactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/neir-substance-vsNEIR ValueSet for Allowed Allergy-related Substancesactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/IMMZ.F.DE2IMMZ.G.DE2 ValueSet for Client Sexactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/neir-clinical-status-vsNEIR ValueSet for Clinical Statusactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/IMMZDContraindicationsIMMZ.D.DE11 ValueSet for Contraindicationsactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/DeviceMaterialCodeVSDevice Material ValueSetactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/IMMZHDisaggregationGroupIMMZ.H.DE42 ValueSet for Disaggregation Groupactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/IMMZDFacilityTypeIMMZ.D.DE2 ValueSet for Facility Typeactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/immzc1-hiv-status-vsIMMZ.C.DE37 ValueSet for HIV Statusactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/NEIRImmunizationNotDoneReasonsVSNEIR ValueSet for Immunization Not Doneactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/IMMZ.F.DE6IMMZ.G.DE6 ValueSet for missed immunizationactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/pregnancy-status-vsIMMZ.C.DE41 ValueSet for Pregnancy Statusdraft2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/IMMZHReportdicaredTypeIMMZ.H.DE22 ValueSet for Report Discarded typesactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/IMMZHReportImprovementIndicatorIMMZ.H.DE34 ValueSet for Report Improvement Indicatoractive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/IMMZDReportIndicatorCodeIMMZ.H.DE10 ValueSet for Report Indicator Codeactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/IMMZHReportStatusIMMZ.H.DE2 ValueSet for Report Statusactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/IMMZHReportTypeIMMZ.H.DE10 ValueSet for Report Indicator Codeactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/IMMZDRouteOfAdministrationIMMZ.D.DE27 ValueSet for Route of Administrationactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/neir-service-request-vsNEIR ValueSet for Service Requestactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/IMMZDSessionTypeIMMZ.D.DE6 ValueSet for Session Typeactive2025-08hl7
fhir.nigeriaImmunizationR4ValueSet/IMMZDSiteAdministeredIMMZ.D.DE21 ValueSet for Site Administeredactive2025-08hl7